Jim Cramer says investors are too focused on AI stocks. Here’s where he says to look instead
CNBC’s Jim Cramer said Tuesday that investors need to expand their horizons beyond the artificial intelligence trade. “There’s…
2 things capping Monday’s market. Plus, Alphabet’s new AI chip plans
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Reality of Trump’s drug pricing to set in over next 18 months
Novartis‘ CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a “very difficult…
Stoxx 600, FTSE, DAX, CAC, Iran latest news
LONDON — European stocks were mixed on Tuesday as investors awaited Washington’s response to Iranian peace proposals and…
Hawkish hold from BOJ sets central bank stage
The Bank of Japan headquarters in Tokyo on May 30, 2024. Kazuhiro Nogi | Afp | Getty Images…
Trump tariffs fall, but trade war impacts linger
A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off…
China vows to continue opening its economy amid U.S. trade tensions
Li Qiang, China’s premier, speaks at the China Development Forum in Beijing, China, on Sunday, March 22, 2026.…
Novartis settles with Henrietta Lacks’ estate over use of her cells
Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited…
15 drugs added to Medicare price negotiations
Boxes of the drug trulicity, made by Eli Lilly and Company, sit on a counter at a pharmacy…
Another alliance of health care and AI signals why pharma stocks could be back
Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the…
I talked to many health CEOs out West and see big things for drug stocks
We get so caught up in the buzz and the sizzle that we forget about the steak, especially…
9 big pharmaceutical companies agree to lower drug prices for Medicaid
U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription…